药物洗脱支架

药物洗脱支架载体材料的选择与优化

Selection and optimization of drug - carrier materials of DES

在药物洗脱支架组，靶血管再血管化率为7.0%，而术后再接受冠脉旁路移植比例为2.2%。

In DES patients , the rate of target-vessel revascularization was7.0 % , and subsequent CABG was performed in2.2 % .

超敏C反应蛋白和脂蛋白a测定在冠状动脉植入药物洗脱支架后发生支架内再狭窄的意义

Hs-CRP and Lipoprotein a as Risk Factors of In-stent Restenosis after Coronary Drug Eluting Stenting

Partner药物洗脱支架在急诊经皮冠状动脉介入治疗中的临床疗效

The clinical outcomes of Partner drug-eluting stent in emergent PCI

EXCEL雷帕霉素药物洗脱支架临床应用安全性及近期疗效评价

The clinical safety and short-term therapeutic efficacy of EXCEL drug-eluting stent

目的评价国产EXCEL雷帕霉素药物洗脱支架临床应用的安全性及疗效。

Objective To evaluate the clinical efficacy and safety of EXCEL drug-eluting stents .

药物洗脱支架应用于ST段抬高型心肌梗死急诊冠状动脉介入治疗临床分析

Clinical analysis of drug-eluting stents in the emergency percutaneous coronary intervention with ST-segment elevation myocardial Infarction

急性冠脉综合征患者药物洗脱支架雷帕霉素Cypher~（TM）植入后的不良反应分析

Analysis of Adverse Reactions of Cypher Drug Eluting Stent Implantation in Treatment of Acute Coronary Syndrome

药物洗脱支架在急性ST段抬高型心肌梗死患者介入术后血栓形成的相关因素分析

Analysis of the related factors of drug-eluting stent thrombosis after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

目前临床常用的有雷帕霉素（Rapamycin）洗脱支架和紫杉醇（paclitaxel）洗脱支架，但药物洗脱支架的使用也面临许多问题，如远期效果、价格昂贵等。

Rapamycin-eluting stent and paclitaxel-eluting stent are used frequently in clinic .

比较应用裸金属支架与药物洗脱支架行经皮冠状动脉介入治疗非ST段抬高型急性冠状动脉综合征对生物标记物水平的影响

Comparison of Effects of Bare Metal Versus Drug-Eluting Stent Implantation on Biomarker Levels Following Percutaneous Coronary Intervention for Non-ST-Eleva-tion Acute Coronary Syndrome

目的探讨应用双药物洗脱支架（ES）疗分叉病变的临床近期疗效。

Objective To evaluate the clinical outcomes of treating bifurcation lesions with two drug-eluting stent ( DES ) techniques .

目的分析近期临床应用冠脉药物洗脱支架（drug-ElutingStent，DES）术后，晚发的支架内急性血栓形成病例的发生特点及可能影响因素。

Objective To systematically analyze the features of cases of late acute thrombosis in coronary drug-eluting stent published recently .

目的：评价紫杉醇药物洗脱支架（TAXUS）应用的临床疗效。

Objective : To evaluation clinical outcomes of paclitaxel-eluting stent ( TAXUS stent ) in patients with complicated lesions .

临床上，在药物洗脱支架（DES）植入术后的患者中，已有1%至2%发生支架断裂。

Background Clinically , stent fracture has been reported in1 % to2 % of patients after drug-eluting stent ( DES ) implantation .

目的探讨药物洗脱支架（ES）多支慢性完全闭塞病变（TO）心病患者的中期疗效和临床意义。

Objective To evaluate mid-term clinical result of drug-eluting stent ( DES ) implantation for patients with multivessel chronic total coronary occlusion ( CTO ) lesions .

雷帕霉素药物洗脱支架Firebird与Cypher的临床对比研究

Clinical contrast investigation of Firebird and Cypher rapamycin eluting stent

目的：观察Cypher雷帕霉素药物洗脱支架在急性ST段抬高心肌梗死（ASTEMI）中的临床研究。

Objective : To investigate the clinical study of cypher drug-eluting stent in patients with acute ST - segment elevation myocardial infarction .

CYPHER药物洗脱支架治疗支架内再狭窄的临床疗效

Rapamycin-Eluting Stents for the Treatment of In-Stent Restenosis

昨日一个热点会议发布，新的研究数据表明与药物洗脱支架（DES）有关的急性冠状动脉综合征死亡率不断增加。

NEW DATA showing increased mortality rates associated with drug eluting stents ( DES ) in acute coronary syndromes were presented in a Hot Line Session yesterday .

Firebird药物洗脱支架在冠心病介入治疗中应用的临床观察

Clinical Observation of Firebird Drug-Eluting Stent in the Interventional therapy of Coronary Heart Disease

方法对21例AMI患者在发病12h内，未经球囊预扩张而直接置入药物洗脱支架。

Methods From March , 2003 to March , 2004 , CYPHER stent was directly deployed without ballon predilation in 21 patients within 12 hours from onset .

背景：载雷帕霉素（Rapamycin）可降解聚合物涂层支架（商品名EXCEL）是使用与目前的药物洗脱支架（DES）不同的聚合物和药物涂层技术制成的新型药物涂层支架。

Backgroud : " EXCEL " is a new kind of stent with rapamycin-coated and biodegradable polymer , different from the current drug-eluting stent ( DES ) .

目的：比较采用紫杉醇药物洗脱支架（PES）和金属裸支架（BMS）治疗弥漫长病变的近期和远期预后。

Objective : To compare paclitaxel-eluting stent ( PES ) with bare-metal stent ( BMS ) in treating complex and diffuse coronary lesions .

目的观察Cypher及Taxus药物洗脱支架治疗冠心病的疗效。

Objective To evaluate the efficacy of Cypher and Taxus drug eluting stent ( DES ) in the treatment of coronary artery diease .

《国际循环》：新的临床试验和注册研究结果已经显示，因为安全性的问题，药物洗脱支架（DES）没有取得对再狭窄的益处。

International Circulation : New clinical trials and registry studies have showed that the benefit of drug-eluting stents in terms of restenosis is not achieved at the expense of a compromised safety .

这些病人当中，47%仅接受普通金属支架治疗（BMS），42%仅接受药物洗脱支架治疗（DES），另5%接受了BMS和DES两种支架治疗。

Of these patients , 47 % received bare-metal stents ( BMS ) only , 42 % drug-eluting stents ( DES ) only , and5 % received both BMS and DES .

两种药物洗脱支架随访无1例发生MACE，心绞痛复发5例。观察出血并发症及冠状动脉内血栓形成的发生率。

Cases of recurred angina . In the two drug-eluting stent groups : there was no case of MACE occurrence ; there were 5 cases of recurred angina .

愈合的不均一性在有LST证据的药物洗脱支架中很常见，这种不均一性也证实了支架部分不完全愈合在LST发病的病理生理学上的重要性。

Heterogeneity of healing is a common finding in drug-eluting stents with evidence of LST and demonstrates the importance of incomplete healing of the stented segment in the pathophysiology of LST .

目前一项最大的药物洗脱支架（DES）与金属裸支架（BMS）长期研究显示，植入DES的患者死亡率并未高于植入BMS的患者。

Mortality rates in patients with drug eluting stents ( DES ) are no higher than with bare metal stents ( BMS ), according to the largest ever long-term study of DES and BMS .